373
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Differential activation mechanisms of serum C5a in lupus nephritis and neuropsychiatric systemic lupus erythematosus

, , &
Pages 292-297 | Received 30 Mar 2016, Accepted 19 May 2016, Published online: 20 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Syoko Tsubouchi, Haeru Hayashi, Koichiro Tahara, Kayo Ishii, Takuya Yasuda, Yusuke Yamamoto, Takahiro Mizuuchi, Hiroaki Mori, Mayu Tago, Eri Kato & Tetsuji Sawada. (2020) Clinical presentation of a neuropsychiatric lupus patient with symmetrical basal ganglia lesions containing cytotoxic oedema cores surrounded by vasogenic oedema. Modern Rheumatology Case Reports 4:1, pages 39-46.
Read now
Kenji Oku & Tatsuya Atsumi. (2018) Systemic lupus erythematosus: nothing stale her infinite variety. Modern Rheumatology 28:5, pages 758-765.
Read now

Articles from other publishers (13)

Jovan Schanzenbacher, Katja Hendrika Kähler, Evelyn Mesler, Marie Kleingarn, Christian Marcel Karsten & Daniel Leonard Seiler. (2023) The role of C5a receptors in autoimmunity. Immunobiology 228:5, pages 152413.
Crossref
Manaswini Ghosh & Soumendra Rana. (2023) The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics. International Immunopharmacology 118, pages 110081.
Crossref
Yoshikazu Kuboi, Yuta Suzuki, Sotaro Motoi, Chiyuki Matsui, Naoki Toritsuka, Tomoya Nakatani, Kazuhiro Tahara, Yoshinori Takahashi, Yoko Ida, Ayaka Tomimatsu, Motohiro Soejima & Toshio Imai. (2023) Identification of potent siRNA targeting complement C5 and its robust activity in pre-clinical models of myasthenia gravis and collagen-induced arthritis. Molecular Therapy - Nucleic Acids 31, pages 339-351.
Crossref
Thomas McDonnell, Raj Amarnani, Carina Spicer, Hajar Jbari, Charis Pericleous, Valentina A Spiteri, Chris Wincup, Bahar Artim-Esen, Ian Mackie, Marina Botto, Anisur Rahman & Ian Giles. (2022) Antibodies to FXa and thrombin in patients with SLE differentially regulate C3 and C5 cleavage. Lupus Science & Medicine 9:1, pages e000738.
Crossref
Bruce T. Volpe, Meggan Mackay, Cynthia Aranow & Betty Diamond. 2021. Lahita's Systemic Lupus Erythematosus. Lahita's Systemic Lupus Erythematosus 231 255 .
J.A. Reynolds & I.N. Bruce. 2021. Lahita's Systemic Lupus Erythematosus. Lahita's Systemic Lupus Erythematosus 661 671 .
Marion Anliker-Ort, Jasper Dingemanse, John van den Anker & Priska Kaufmann. (2020) Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway. Frontiers in Immunology 11.
Crossref
Falk Hiepe. (2020) Neue Erkenntnisse zur Pathogenese des SLE und ihre Auswirkungen auf die Entwicklung neuer Therapie-Konzepte. Aktuelle Rheumatologie 45:04, pages 328-333.
Crossref
Hisanori Umehara & Mitsuhiro Kawano. (2019) Response to: ‘Serum complement factor C5a in IgG4-related disease’ by Fukui et al . Annals of the Rheumatic Diseases 78:7, pages e66-e66.
Crossref
Noa Schwartz, Ariel D. Stock & Chaim Putterman. (2019) Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nature Reviews Rheumatology 15:3, pages 137-152.
Crossref
Ariel D. Stock, Ayal Ben-Zvi & Chaim Putterman. 2019. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes 317 323 .
Masakazu Yoneda, Ryuji Imamura, Hidetoshi Nitta, Keisuke Taniguchi, Fumitaka Saito, Ken Kikuchi, Hidenao Ogi, Takuya Tanaka, Hidetaka Katabuchi, Hideki Nakayama & Takahisa Imamura. (2018) Enhancement of cancer invasion and growth via the C5a‑C5a receptor system: Implications for cancer promotion by autoimmune diseases and association with cervical cancer invasion. Oncology Letters.
Crossref
Shunsei Hirohata. 2018. Neuropsychiatric Systemic Lupus Erythematosus. Neuropsychiatric Systemic Lupus Erythematosus 29 42 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.